Publicly funded exome sequencing for outpatients with neurodevelopmental disorders demonstrates a high rate of unexpected findings impacting medical management
Purpose: Exome sequencing (ES) is a powerful tool that facilitates the diagnosis of patients with rare Mendelian syndromes. In 2018 the Israeli Ministry of Health initiated a national pilot program that funds ES for outpatients with global developmental delay (GDD). Here, we describe the 3-year impa...
Main Authors: | Yara Nakhleh Francis, Tova Hershkovitz, Nina Ekhilevitch, Clair Habib, Sarit Ravid, Galit Tal, Mitchell Schertz, Adi Mory, Amihood Zinger, Hagit Baris Feldman, Rinat Zaid, Tamar Paperna, Karin Weiss |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Genetics in Medicine Open |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2949774423008373 |
Similar Items
-
Rare Disease Diagnostics: A Single-center Experience and Lessons Learnt
by: Karin Weiss, et al.
Published: (2018-07-01) -
A recurring NFS1 pathogenic variant causes a mitochondrial disorder with variable intra-familial patient outcomes
by: Tova Hershkovitz, et al.
Published: (2021-03-01) -
Exome sequencing identifies novel and known mutations in families with intellectual disability
by: Memoona Rasheed, et al.
Published: (2021-08-01) -
The Genetics of Asymmetry: Whole Exome Sequencing in a Consanguineous Turkish Family with an Overrepresentation of Left-Handedness
by: Sebastian Ocklenburg, et al.
Published: (2017-05-01) -
Parental consanguinity increases the risk of congenital malformations
by: Maheen Gul, et al.
Published: (2021-06-01)